Clinical Trials Directory

Trials / Completed

CompletedNCT03148717

Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section

Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section: A Randomized, Double Blind Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This prospective double-blind placebo-controlled randomized clinical trial will be conducted at Ain-Shams University Maternity Hospital from April 2017 till December 2017. Group 1 women, candidates for cesarean section, will receive preoperative rectal 400 microgram of misoprostol, and Group 2 women will receive postoperative rectal 400 microgram of misoprostol. 2017\. 120 women candidate foe elective cesarean section will receive preoperative sublingual 400 microgram of misoprostol, and another 120 women will receive postoperative sublingual 400 microgram of misoprostol.

Conditions

Interventions

TypeNameDescription
DRUGMisoprostolCytotec
OTHERPlaceboPlacebo tablet similar in shape, odour and consistency to misoprostol tablet.

Timeline

Start date
2017-05-10
Primary completion
2018-03-02
Completion
2018-03-20
First posted
2017-05-11
Last updated
2018-03-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03148717. Inclusion in this directory is not an endorsement.

Preoperative vs. Postoperative Rectal Misoprostol in Cesarean Section (NCT03148717) · Clinical Trials Directory